NBIA (neurodegeneration with brain iron accumulation), previously known as Hallervorden-Spatz disease (HSD), is a rare inherited progressive neurological disorder.
NBIA, also known as HSD, is a genetic disorder caused by defects that affect the PANK2 gene, the gene containing the instructions for the protein PANK2, which regulates the creation of coenzyme A. This enzyme plays an important role in the metabolism of fats and carbohydrates to produce energy.
It may also be possible that other genes are involved, however these specific genes have not yet been identified.
Most cases develop in childhood, although adult onset is possible. Family history increases your risk of developing NBIA.
If your GP suspects that your symptoms may be suggestive of NBIA, they will refer you for further neurological tests to confirm a diagnosis. These tests will be used to detect problems such as seizures and tremors, muscle weakness, rigidity in the muscles and abnormal posture. Genetic testing is not used widely for NBIA diagnosis.
NBIA can cause a wide range of symptoms and people can be affected in different ways. Some cases are more severe than others. Common symptoms include:
Symptoms that occur less commonly include:
Sometimes, a lack of mobility and movement can increase the risk of complications such as bed sores, blood clots and skin damage.
There is currently no cure for NBIA and treatments are used to reduce the severity of symptoms, make you feel more comfortable and improve movement.
Treatment options include:
Cases that develop during childhood tend to be more severe and symptoms progress quickly. Life expectancy is shortened significantly.